What does MEDILEX VAN LAETHEM do?

MEDILEX VAN LAETHEM is a general practice in Lennik. Private Limited, started on 21 December 2009, 1 establishment.

What is the address of MEDILEX VAN LAETHEM?

The registered office of MEDILEX VAN LAETHEM is located at Karel Keymolenstraat 70, 1750 Lennik.

Is MEDILEX VAN LAETHEM still active?

Yes. According to the CBE (29 September 2026) MEDILEX VAN LAETHEM is active, legal situation “Normale toestand”, started on 21 December 2009.

Is MEDILEX VAN LAETHEM registered on Peppol?

Yes, MEDILEX VAN LAETHEM is registered on the Peppol network with ID 0208:0821644933.

What is the enterprise number of MEDILEX VAN LAETHEM?

The enterprise number of MEDILEX VAN LAETHEM is BE0821644933.

When was MEDILEX VAN LAETHEM founded?

MEDILEX VAN LAETHEM was founded on 21 December 2009.

Who are the directors of MEDILEX VAN LAETHEM?

According to the 2024 annual accounts, the directors of MEDILEX VAN LAETHEM are: ALAIN VAN LAETHEM.

Is MEDILEX VAN LAETHEM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 December 2009; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did MEDILEX VAN LAETHEM make in 2024?

MEDILEX VAN LAETHEM posted a profit after taxes of € 22,584 in financial year 2024.

What is the revenue of MEDILEX VAN LAETHEM?

As a small company, MEDILEX VAN LAETHEM is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 100,180.

MEDILEX VAN LAETHEM (Private Limited) - Lennik

Dossier MEDILEX VAN LAETHEM, printed on 29 September 2026 from databakkes.be/en/0821644933/medilex-van-laethem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2021.

Financials

Financial year 2024

MEDILEX VAN LAETHEM from Lennik, company number BE0821644933, closed financial year 2024 with a result of € 22,584 after tax. For that financial year MEDILEX VAN LAETHEM recorded a gross margin of € 100,180 and equity of € 184,128. Compared with financial year 2023, the result moved from € 30,047 to € 22,584. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.

What it is worth Growing

€ 184,128

▲ 14% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 22,584

▼ 25% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 26,955

▲ 39% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 171,728.

People and assets in 2024

Wage cost

€ 34,128

▲ 6% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,867

▲ 3% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 324,686

▼ 9% vs 2023

€ 33,803 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 5,808

▼ 15% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 15,956

▲ 29% vs 2023

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 97,780 Gross margin 2021: € 97,780 First fiscal year in the series	€ 103,960 Gross margin 2022: € 103,960 ▲ 6% vs 2021 (€ 97,780) Favourable step	€ 107,595 Gross margin 2023: € 107,595 ▲ 3% vs 2022 (€ 103,960) Favourable step	€ 100,180 Gross margin 2024: € 100,180 ▼ 7% vs 2023 (€ 107,595) Unfavourable step	▼ 7%
Profit after taxes	€ 27,999 Profit after taxes 2021: € 27,999 First fiscal year in the series	€ 30,256 Profit after taxes 2022: € 30,256 ▲ 8% vs 2021 (€ 27,999) Favourable step	€ 30,047 Profit after taxes 2023: € 30,047 ▼ 1% vs 2022 (€ 30,256) Unfavourable step	€ 22,584 Profit after taxes 2024: € 22,584 ▼ 25% vs 2023 (€ 30,047) Unfavourable step	▼ 25%
Equity	€ 125,242 Equity 2021: € 125,242 First fiscal year in the series	€ 131,498 Equity 2022: € 131,498 ▲ 5% vs 2021 (€ 125,242) Favourable step	€ 161,545 Equity 2023: € 161,545 ▲ 23% vs 2022 (€ 131,498) Favourable step	€ 184,128 Equity 2024: € 184,128 ▲ 14% vs 2023 (€ 161,545) Favourable step	▲ 14%
Total debts	€ 422,542 Total debts 2021: € 422,542 First fiscal year in the series	€ 397,893 Total debts 2022: € 397,893 ▼ 6% vs 2021 (€ 422,542) Favourable step	€ 376,490 Total debts 2023: € 376,490 ▼ 5% vs 2022 (€ 397,893) Favourable step	€ 346,683 Total debts 2024: € 346,683 ▼ 8% vs 2023 (€ 376,490) Favourable step	▼ 8%
Cash	€ 20,836 Cash 2021: € 20,836 First fiscal year in the series	€ 19,624 Cash 2022: € 19,624 ▼ 6% vs 2021 (€ 20,836) Unfavourable step	€ 19,337 Cash 2023: € 19,337 ▼ 1% vs 2022 (€ 19,624) Unfavourable step	€ 26,955 Cash 2024: € 26,955 ▲ 39% vs 2023 (€ 19,337) Favourable step	▲ 39%
Land & buildings	€ 451,260 Land & buildings 2021: € 451,260 First fiscal year in the series	€ 441,450 Land & buildings 2022: € 441,450 ▼ 2% vs 2021 (€ 451,260) Unchanged	€ 431,640 Land & buildings 2023: € 431,640 ▼ 2% vs 2022 (€ 441,450) Unchanged	€ 421,830 Land & buildings 2024: € 421,830 ▼ 2% vs 2023 (€ 431,640) Unchanged	▼ 2%
Retained profit	€ 112,842 Retained profit 2021: € 112,842 First fiscal year in the series	€ 119,098 Retained profit 2022: € 119,098 ▲ 6% vs 2021 (€ 112,842) Favourable step	€ 149,145 Retained profit 2023: € 149,145 ▲ 25% vs 2022 (€ 119,098) Favourable step	€ 171,728 Retained profit 2024: € 171,728 ▲ 15% vs 2023 (€ 149,145) Favourable step	▲ 15%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 24,000 Dividend 2022: € 24,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 24,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 408,629 Bank debt 2021: € 408,629 First fiscal year in the series	€ 380,177 Bank debt 2022: € 380,177 ▼ 7% vs 2021 (€ 408,629) Favourable step	€ 357,103 Bank debt 2023: € 357,103 ▼ 6% vs 2022 (€ 380,177) Favourable step	€ 324,686 Bank debt 2024: € 324,686 ▼ 9% vs 2023 (€ 357,103) Favourable step	▼ 9%
Balance sheet total	€ 547,784 Balance sheet total 2021: € 547,784 First fiscal year in the series	€ 529,391 Balance sheet total 2022: € 529,391 ▼ 3% vs 2021 (€ 547,784) Unchanged	€ 538,035 Balance sheet total 2023: € 538,035 ▲ 2% vs 2022 (€ 529,391) Unchanged	€ 530,811 Balance sheet total 2024: € 530,811 ▼ 1% vs 2023 (€ 538,035) Unchanged	▼ 1%

Key figures of MEDILEX VAN LAETHEM, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to MEDILEX VAN LAETHEM?

What happened at MEDILEX VAN LAETHEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 29, 2025 New annual accounts for financial year 2024: profit of € 22,584 (▼ 25% vs 2023). filed late Source: NBB ↗
Jan 1, 2010 New establishment in Lennik. KBO
Dec 21, 2009 Start of the company according to the CBE. KBO

In short

From € 27,999 profit in 2021 to € 22,584 profit in 2024.

Paid € 49,546 in corporate taxes since 2021.

Best year ever: 2022, with € 30,256 profit.

Paid out € 24,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at MEDILEX VAN LAETHEM? We notify you, reason included.

Follow MEDILEX VAN LAETHEM

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

ALAIN VAN LAETHEM

MEDILEX VAN LAETHEM

Behind MEDILEX VAN LAETHEM is ALAIN VAN LAETHEM.

See the full network in the app

Directors

According to the 2024 annual accounts

ALAIN VAN LAETHEM

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Karel Keymolenstraat 70

1750 Lennik

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0821.644.933
VAT number: BE 0821.644.933
Registered office: Karel Keymolenstraat 70, 1750 Lennik
Names & denominations: MEDILEX VAN LAETHEM
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 December 2009
Peppol: Active · Active since 15 Sept 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗